Hexamethylene bisacetamide induces programmed cell death (apoptosis) and down-regulates BCL-2 expression in human myeloma cells

Proceedings of the National Academy of Sciences of the United States of America

Volumn 95, Issue 1, 1998, Pages 162-166

  Siegel, D S ^a   Zhang, X ^b   Feinman, R ^a   Teitz, T ^b   Zelenetz, A ^b   Richon, V M ^b   Rifkind, R A ^b   Marks, P A ^b   Michaeli, J ^b  

^a UNIVERSITY OF ARKANSAS AT LITTLE ROCK   (United States)

^b MEMORIAL SLOAN KETTERING CANCER CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

DNA FRAGMENT; DOXORUBICIN; GLYCOPROTEIN P; HEXAMETHYLENEBISACETAMIDE; MULTIDRUG RESISTANCE PROTEIN; PROTEIN BCL 2;

APOPTOSIS; CELL CYCLE; CLONOGENESIS; CONFERENCE PAPER; CONTROLLED STUDY; GROWTH INHIBITION; HUMAN; HUMAN CELL; MULTIDRUG RESISTANCE; MULTIPLE MYELOMA; MYELOMA CELL; NUCLEOSOME; PRIORITY JOURNAL; PROTEIN EXPRESSION;

EID: 0031892734     PISSN: 00278424     EISSN: None     Source Type: Journal    
DOI: 10.1073/pnas.95.1.162     Document Type: Article

References (28)

1. Michaeli, J., Rifkind, R. A. & Marks, P. A. (1992) Cancer Chemother. Biol. Response Modifiers 13, 287-307.
2. Marks, P. A., Richon, V. M., Kiyokawa, H. & Rifkind, R. A. (1994) Proc. Natl. Acad. Sci. USA 91, 10251-10254.
3. Williams, G. T. (1991) Cell 65, 1097-1098.
4. Williams, G. T. & Smith, C. A. (1993) Cell 74, 777-779.
5. Richon, V. M., Russo, P., Venta-Perez, G., Cordon-Cardo, C., Rifkind, R. A. & Marks, P. A. (1997) Cancer Res. 57, 2789-2798.
6. Niesvizky, R., Siegel, D. & Michaeli, J. (1993) Blood Rev. 7, 24-33.
7. Dalton, W. S. & Salmon, S. E. (1992) Hematol. Oncol. Clin. North Am. 6, 383-393.
8. Zhang, X., Childs, B., Siegel, D., Rameche, Y., Zelenetz, A. & Michaeli, J. (1994) Blood 84, 175a.
9. Lichtenstein, A., Tu, Y., Pady, C., Vescio, R. & Berenson, J. (1995) Cell. Immunol 162, 248-255.
10. Pettersson, M., Jernberg-Wiklund, H., Larsson, L.-G., Sundstrom, C., Givol, I., Tsujimoto, Y. & Nilsson, K. (1992) Blood 79, 495-502.
11. Tu, Y., Xu, F.-H., Liu, J., Vescio, R., Berenson, J., Fady, C. & Lichtenstein, A. (1996) Blood 88, 1805-1812.
12. Miyashita, T. & Reed, J. C. (1993) Blood 81, 151-157.
13. Hannum, Y. A. (1997) Blood 89, 1845-1853.
14. Li, X. & Darzynkiewicz, Z. (1995) Cell Prolif. 28, 571-579.
15. Herrmann, M., Lorenz, H.-M., Voll R., Grunke, M., Woith W. & Kalden J. R. (1994) Nucleic Acids Res. 22, 5506-5507.
16. Bradford, M. M. (1976) Ann. Biochem. 72, 248-252.
17. Hardin, J., MacLeod, S., Grigorieva, I., Chang, R., Barlogie, B., Ziao, H. & Epstein, J. (1994) Blood 84, 3063-3070.
18. Gorezyca, W., Gong, J., Ardelt, B., Traganos, F. & Darzynkiewicz Z. (1993) Cancer Res. 53, 3186-3192.
19. Gavrieli, Y., Sherman, Y. & Ben-Sasson, S. A. (1992) J. Cell Biol. 119, 493-501.
20. Schwarze, M. M. K. & Hawley, R. G. (1995) Cancer Res. 55, 2262-2265.
21. Landanyi, M., Wang, S., Niesvizky, R., Feiner, H. & Michaeli, J. (1992) Am. J. Pathol. 141, 949-953.
22. Bhatia, U., Traganos, F. & Darzynkiewicz, Z. (1995) Cell Growth Differ. 6, 937-944.
23. Sentman, C. L., Shutter, J. R., Hockenbery, D., Kanagawa O. & Korsmeyer, S. J. (1991) Cell 67, 879-888.
24. Naumovski, L. & Cleary, M. L. (1994) Blood 83, 2261-2267.
25. Park, J. R., Robertson, K., Hickstein, D. D., Tsai, S., Hockenbery, D. M. & Collins, S. J. (1994) Blood 84, 440-445.
26. Fairbairn, L. J., Cowling, G. J., Reipert, B. M. and Dexter, T. M. (1993) Cell 74, 823-832.
27. Hueng, Y. & Waxman, S. (1994) Mol. Cell Differ. 2, 83-100.
28. Andreeff, M., Stone, R., Michaeli, J., Young, C. E., Tong, W. F., Sogoloff, H., Ervin, T., Kufe, D., Rifkind, R. A. & Marks, P. A. (1992) Blood 80, 2604-2609.